Palvella Therapeutics Inc.
XNAS: PVLA
Palvella Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapa...
Read More
76.69
-5.21
(-6.36%)
556.5K
XNAS Volume
High volume+loss today
XNAS 30 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Palvella Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..